254 related articles for article (PubMed ID: 11382718)
1. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.
Pasceri V; Cheng JS; Willerson JT; Yeh ET
Circulation; 2001 May; 103(21):2531-4. PubMed ID: 11382718
[TBL] [Abstract][Full Text] [Related]
2. Impact of simvastatin and losartan on antiinflammatory effect: in vitro study.
Chang LT; Sun CK; Chiang CH; Wu CJ; Chua S; Yip HK
J Cardiovasc Pharmacol; 2007 Jan; 49(1):20-6. PubMed ID: 17261959
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Dragomir E; Tircol M; Manduteanu I; Voinea M; Simionescu M
Vascul Pharmacol; 2006 Jun; 44(6):440-9. PubMed ID: 16600694
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells.
Lin R; Liu J; Gan W; Yang G
Biol Pharm Bull; 2004 Oct; 27(10):1537-43. PubMed ID: 15467191
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.
Rival Y; Benéteau N; Taillandier T; Pezet M; Dupont-Passelaigue E; Patoiseau JF; Junquéro D; Colpaert FC; Delhon A
Eur J Pharmacol; 2002 Jan; 435(2-3):143-51. PubMed ID: 11821020
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress.
Huang X; Zhang J; Liu J; Sun L; Zhao H; Lu Y; Wang J; Li J
J Cell Biochem; 2012 Mar; 113(3):857-67. PubMed ID: 22020763
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide.
Taylor KE; Giddings JC; van den Berg CW
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1225-30. PubMed ID: 15802626
[TBL] [Abstract][Full Text] [Related]
10. PPAR activators inhibit endothelial cell migration by targeting Akt.
Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
[TBL] [Abstract][Full Text] [Related]
11. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Zhang H; Issekutz AC
Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell activation by C-reactive protein.
Hattori Y; Matsumura M; Kasai K
Cardiovasc Res; 2003 Apr; 58(1):186-95. PubMed ID: 12667961
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins.
Amberger A; Hala M; Saurwein-Teissl M; Metzler B; Grubeck-Loebenstein B; Xu Q; Wick G
Mol Med; 1999 Feb; 5(2):117-28. PubMed ID: 10203577
[TBL] [Abstract][Full Text] [Related]
14. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.
Verma S; Li SH; Badiwala MV; Weisel RD; Fedak PW; Li RK; Dhillon B; Mickle DA
Circulation; 2002 Apr; 105(16):1890-6. PubMed ID: 11997273
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein can influence the proliferation, apoptosis, and monocyte chemotactic protein-1 production of human umbilical vein endothelial cells.
Guo S; Meng S; Chen B; Liu J; Gao L; Wu Y
DNA Cell Biol; 2011 Mar; 30(3):157-62. PubMed ID: 20979529
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease.
Poddar R; Sivasubramanian N; DiBello PM; Robinson K; Jacobsen DW
Circulation; 2001 Jun; 103(22):2717-23. PubMed ID: 11390343
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein induces NF-kappaB activation through intracellular calcium and ROS in human mesangial cells.
Chang JW; Kim CS; Kim SB; Park SK; Park JS; Lee SK
Nephron Exp Nephrol; 2005; 101(4):e165-72. PubMed ID: 16131811
[TBL] [Abstract][Full Text] [Related]
20. Direct proinflammatory effect of C-reactive protein on human endothelial cells.
Pasceri V; Willerson JT; Yeh ET
Circulation; 2000 Oct; 102(18):2165-8. PubMed ID: 11056086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]